Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2147/IDR.S264020 http://scihub22266oqcxt.onion/10.2147/IDR.S264020 32801804!7413717!32801804     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Infect+Drug+Resist 2020 ; 13 (ä): 2657-2665 Nephropedia Template TP {{tp|p=32801804|t=2020. Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review |pdf=|usr=}}{{32801804}} gab.com Text Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review JO: Infect Drug Resist http://www.kidney.de/pget.php?&tw=1&pmid=32801804 #FOAvip The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the related disease (COVID-19) has spread rapidly to pandemic proportions, increasing the demands on healthcare systems for the containment and management of COVID-19. One of the critical issues to be addressed is the improvement in laboratory diagnosis and screening of large portions of the population to stop the virus spreading. Currently, the laboratory diagnosis of SARS-CoV-2 infection and the related disease is based on the research of viral RNA with rt-PCR methods in upper and lower respiratory airways. Serological tests to detect SARS-CoV-2 antibodies could help physicians and healthcare workers to support COVID-19 diagnosis and follow-up and perform population screening. Our review, using MEDLINE and EMBASE, summarizes the current knowledge of direct and serological tests performed to research RNA, antigens, or antibodies for SARS-CoV-2, evaluating the advantages and drawbacks for specific tests. Twit Text FOAVip Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review ????Infect Drug Resist http://www.kidney.de/pget.php?&tw=1&pmid=32801804 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32801804 #FOAvip English Wikipedia <ref>{{Cite pmid|32801804}}</ref> Current Status of Laboratory Diagnosis for COVID-19: A Narrative Review #MMPMID32801804 Russo A; Minichini C; Starace M; Astorri R; Calo F; Coppola N Infect Drug Resist 2020[]; 13 (ä): 2657-2665 PMID32801804show ga The outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the related disease (COVID-19) has spread rapidly to pandemic proportions, increasing the demands on healthcare systems for the containment and management of COVID-19. One of the critical issues to be addressed is the improvement in laboratory diagnosis and screening of large portions of the population to stop the virus spreading. Currently, the laboratory diagnosis of SARS-CoV-2 infection and the related disease is based on the research of viral RNA with rt-PCR methods in upper and lower respiratory airways. Serological tests to detect SARS-CoV-2 antibodies could help physicians and healthcare workers to support COVID-19 diagnosis and follow-up and perform population screening. Our review, using MEDLINE and EMBASE, summarizes the current knowledge of direct and serological tests performed to research RNA, antigens, or antibodies for SARS-CoV-2, evaluating the advantages and drawbacks for specific tests. äCurrent Status of Laboratory Diagnosis for COVID-19: A Narrative Revie(epmc).pdf DeepDyve Pubget Overpricing